Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 4, 2015, Pages 404-412

  Llordés, Montserrat ^a   Jaén, Angeles ^a   Almagro, Pere ^b   Heredia, Josep Luis ^a   Morera, Josep ^c   Soriano, Joan B ^d   Miravitlles, Marc ^e  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

case finding; co morbidity; COPD; differential diagnoses; prevalence; primary care; tobacco

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; FORMOTEROL;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIAGNOSTIC ACCURACY; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SPIROMETRY; TREATMENT DURATION; ADVERSE EFFECTS; CLINICAL TRIAL; DIAGNOSTIC ERROR; FOLLOW UP; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPAIN; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPAIN; SPIROMETRY;

EID: 84939420256     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.974736     Document Type: Article

References (33)

1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341-1351
2. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374: 721-732
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-Analysis. Eur Respir J 2006; 28: 523-532
4. Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750
5. Miravitlles M, Soriano JB, GarcÍa-RÍo F, MuÓoz L, Duran-TaulerÍa E, Sánchez G, et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-868
6. Decramer M, Miravitlles M, Price D, Román-RodrÍguez M, Llor C, Welte T, et al. New horizons in early stage COPD-Improving knowledge, detection and treatment. Respir Med 2011; 105: 1576-1587
7. Jones RCM, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014,. forthcoming
8. Monteagudo M, Rodriguez-Blanco T, Parcet J, PeÓalver N, Rubio C, Ferrer M, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in Primary Care. Arch Bronconeumol 2011; 47: 226-233
9. Van Schayck C, Loozen J, Wagena E, Akkermans R, Wesseling G. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. Br Med J 2002; 324: 1370
10. Jordan RE, Lam KH, Cheng KK, Miller MR, Marsh JL, Ayres JG, et al. Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach. Thorax 2010; 65: 492-498
11. Miravitlles M, Andreu I, Romero Y, Sitjar S, AltÉs A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract 2012; 62: e68-e75
12. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006; 28: 945-952
13. Castell E, Garolera D, Vilella A, Grenzer V, Canela J. AdaptaciÓ al catal‡ de l'enquesta de malalties respiratories ATS-DLD-78. ValidaciÓ preliminar. Ann Med (Barc) 1988; 74: 231-239
14. Monsó E, Ribas J, Carreres A, Izquierdo J, Alvarez J, Fiz J, et al. Diseóo de un cuestionario ocupacional para ser utilizado en la práctica neumolÓgica diaria. Ann Med (Barc) 1993; (3): 43-46
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry. Eur Respir J 2005; 26: 319-338
16. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez R, et al. Spirometric reference values from Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224
17. Vestbo J, Hurd SS, AgustÍ AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365
18. GLI-2012 Desktop Software for Data Sets. http://www.lungfunction.org/tools/90-equations-And-Tools/196-obtain-software.html (accessed 10 May, 2014
19. Vidal R, Blanco I, Casas F, JardÍ R, Miravitlles M. Guidelines for the diagnosis and management of alpha-1antitrypsin deficiency. Arch Bronconeumol 2006; 42: 645-659
20. RodrÍguez F, JardÍ R, Costa X, Cotrina M, Galimany R, Vidal R, et al. Rapid screening for alpha-1-Antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood spots. Am J Respir Crit Care Med 2002; 166: 814-817
21. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191
22. Sobradillo PeÓa V, Miravitlles M, Gabriel R, JimÉnez-Ruiz C, Villasante C, Masa J, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118 (4): 981-989
23. Jaén Díaz J, de Castro Mesa C, Gontán García-Salamanca M, López de Castro F. Prevalencia y factores de riesgo de EPOC en fumadores y ex fumadores. Arch Bronconeumol 2003; 39: 554-558
24. Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J 2007; 9: 800-802
25. De Torres J, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006; 73: 306-310
26. Finkelstein J, Cha E, M Scharf S. Chronic obstructive pulmonary disease as an independent risk factor cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4: 337-349
27. Miravitlles M, Soler-CataluÓa JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish Guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 2014; 50 (Suppl 1): 1-16
28. Molloy K, Hersh CP, Morris VB, Carroll TP, O'Connor CA, Lasky-Su J, et al. Clarification of the risk of chronic obstructive pulmonary disease in alpha1-Antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014; 189: 419-427
29. Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabriel R, et al. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 2005; 99: 985-995
30. Medbo A, Melbye H. Lung function testing in the elderly-Can we still use FEV1/FVC<70% as a criterion for COPD? Respir Med 2007; 101: 1097-1105
31. Akkermans RP, Berrevoets MA, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, et al. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012; 12: 12
32. Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-Term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774
33. Barisione G, Crimi E, Bartolini S, Saporiti R, Copello F, Pellegrino R, et al. How to interpret reduced forced expiratory volume in 1 s (FEV 1)/vital capacity ratio with normal FEV 1. Eur Respir J 2009; 33: 1396-1402